Related Experiment Video
Updated: Jul 19, 2026
06:55
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Special considerations in pediatric lung transplantation.
1Department of Pediatrics, Division of Allergy and Pulmonary Medicine, Washington University in St. Louis School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri 63110, USA.
Seminars in Respiratory and Critical Care Medicine
|October 31, 2006
Summary
Pediatric lung transplantation offers improved quality of life but presents unique challenges compared to adults. Collaborative studies are crucial for enhancing long-term outcomes in young lung transplant recipients.
Area of Science:
- Pediatric pulmonology
- Thoracic surgery
- Transplant medicine
Background:
- Over 1300 pediatric lung or heart-lung transplants have been performed, significantly enhancing quality of life.
- Pediatric lung transplantation is distinct from adult transplantation, with unique indications, complications, and management needs.
- Key indications in children include cystic fibrosis and pulmonary vascular disease, differing from adult recipient profiles.
Purpose of the Study:
- To highlight the unique aspects of pediatric lung transplantation compared to adult procedures.
- To identify common and distinct complications in pediatric lung transplant recipients.
- To emphasize the need for specialized approaches for infants and adolescents and address donor limitations.
Main Methods:
- Review of existing data and clinical experience from over 1300 pediatric lung or heart-lung transplants.
- Comparative analysis of indications, complications, pharmacokinetics, and monitoring between pediatric and adult lung transplant recipients.
- Consideration of specific challenges in pediatric populations, including donor organ availability and allocation systems.
Main Results:
- Pediatric lung transplant recipients face distinct complications, including higher rates of posttransplant lymphoproliferative disorders, growth retardation, infections, and nonadherence.
- Graft dysfunction and bronchiolitis obliterans occur with similar frequency as in adults.
- Donor shortage remains a significant challenge, though living donor lobar transplantation offers an alternative for some candidates.
Conclusions:
- Pediatric lung transplantation is a unique field requiring specialized care, distinct from adult transplantation.
- Addressing specific complications and considering the unique needs of infants and adolescents is vital for improving outcomes.
- Continued support for collaborative research is essential to overcome challenges like donor organ scarcity and enhance long-term survival for pediatric lung transplant recipients.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...